Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10407479 Mutant FGF-21 peptide pegylated conjugates and uses thereof

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Patrick Mengyuan Liu0

Karla K. Kopec0

Date of Patent

September 10, 2019

0

Patent Application Number

162256400

Date Filed

December 19, 2018

0

Patent Citations

US Patent 10189883 Therapeutic uses of modified FGF-21 polypeptides

Patent Citations Received

US Patent 11850275 Liquid formulations comprising mutant FGF-21 peptide pegylated conjugates

0

US Patent 11596669 Liquid formulations comprising mutant FGF-21 peptide pegylated conjugates

US Patent 11427623 Methods of treatment using mutant FGF-21 peptide conjugates

US Patent 11510990 Conjugates of fusion proteins of GLP-1 and FGF21

Patent Primary Examiner

Christine J. Saoud

0

Patent abstract

The present invention relates to a mutant Fibroblast Growth Factor-21 (FGF-21) peptide conjugate comprising a PEG moiety attached to a mutant FGF-21 peptide via a glycosyl linker and uses thereof. Further provided is a method for producing the mutant FGF-21 peptide conjugate and a pharmaceutical composition and container comprising said mutant FGF-21 peptide conjugate.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10407479 Mutant FGF-21 peptide pegylated conjugates and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool